Results Snapshot
YoYQoQ
Figures in Cr
Standalone Quarterly Results
Jun'24
Mar'24
Dec'23
Sep'23
Jun'23
Mar'23
Dec'22
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2024 is 0.00% vs 0.00% in Mar 2024
Standalone Net Profit
QoQ Growth in quarter ended Jun 2024 is -5.56% vs -2.44% in Mar 2024
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2024 is -36.00% vs -25.00% in Mar 2024
Interest
No Interest in the last few periods
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2024 has improved from Mar 2024
Compare Quarterly Results Of Kobo Biotech With
Figures in Cr
Standalone Quarterly Results
Change(INR)
Change(%)
Net Sales
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.00
0.00
0.00
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
0.07
0.00
0.07
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.27
0.05
0.22
440.00%
Total Expenditure (Excl Depreciation)
0.34
0.05
0.29
580.00%
Operating Profit (PBDIT) excl Other Income
-0.34
-0.05
-0.29
-580.00%
Other Income
0.02
0.00
0.02
Operating Profit (PBDIT)
-0.32
-0.05
-0.27
-540.00%
Interest
0.00
0.13
-0.13
-100.00%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
-0.32
-0.18
-0.14
-77.78%
Depreciation
1.01
0.01
1.00
10,000.00%
Profit Before Tax
-1.33
-0.19
-1.14
-600.00%
Tax
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-1.33
-0.19
-1.14
-600.00%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-1.33
-0.19
-1.14
-600.00%
Equity Capital
23.83
6.08
17.75
291.94%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
-0.56
-0.31
-0.25
-80.65%
Diluted Earnings per share
-0.56
-0.32
-0.24
-75.00%
Operating Profit Margin (Excl OI)
0.00%
0.00%
0.00
0.00%
Gross Profit Margin
0.00%
0.00%
0.00
0.00%
PAT Margin
0.00%
0.00%
0.00
0.00%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
No Net Sales in the last few periods
Quarterly - Standalone Net Profit
Standalone Net Profit -1.33 Cr
in Jun 2024Figures in Cr
QoQ Growth in quarter ended Jun 2024 is -5.56% vs -2.44% in Mar 2024
YoY Growth in quarter ended Jun 2024 is -8.13% vs 16.33% in Jun 2023
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.34 Cr
in Jun 2024Figures in Cr
QoQ Growth in quarter ended Jun 2024 is -36.00% vs -25.00% in Mar 2024
YoY Growth in quarter ended Jun 2024 is -47.83% vs 30.30% in Jun 2023
Quarterly - Interest
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
No Operating Profit Margin (Excl OI) in the last few periods






